Literature DB >> 33907905

Clinical characteristics of pulmonary artery involvement in patients with Behçet's syndrome: single-centre experience of 61 patients.

Didem Sahin Eroglu1, Murat Torgutalp2, Serdar Baysal3, Anil Colaklar4, Serdar Sezer2, Mucteba Enes Yayla2, Caglar Uzun4, Tahsin Murat Turgay2, Gulay Kinikli2, Askin Ates2.   

Abstract

OBJECTIVE: To report the clinical characteristics of pulmonary artery involvement (PAI) in patients with Behçet's syndrome (BS) and to define the predictors of relapses.
METHODS: We performed retrospective analysis of BS patients with PAI who fulfilled international study group criteria. Among 460 patients with vascular Behçet's syndrome (VBS), 66 were diagnosed with PAI. For final analyses, 61 patients with PAI were included who had at least 2 follow-up visits (72.1% male, mean age at BS diagnosis 29.34 ± 10.1 years). The patient data were recorded. Relapse was defined as the reoccurrence of vascular event in any vascular structure. Factors associated with relapse were assessed by logistic regression analysis.
RESULTS: There were no differences considering demographic and clinical features of the patients with and without PAI in the VBS group, except that intracardiac thrombosis was more common in the patients with PAI (19.7% vs 0.3%). Among 61 patients, 50 (82.0%) had isolated pulmonary artery thrombosis (PAT), whereas 11 (18.0%) had pulmonary artery aneurysm with or without PAT. Twenty-four (39.3%) patients experienced vascular relapse during median follow-up of 65.9 (Q1-Q3: 20.1-109.0) months. To define the factors associated with relapses, patients with isolated PAT were analysed. On multivariable logistic regression analysis, older age at BS diagnosis and anticoagulation usage seemed to be protective (OR: 0.92, 95% CI 0.86-1.02, OR: 0.34, 95% CI 0.09-1.33, respectively).
CONCLUSION: Our results indicate a higher frequency of intracardiac thrombosis in BS patients with PAI and possible efficacy of anticoagulation usage in preventing relapses. Key Points • This study shows that intracardiac and intracranial thromboses are seen more frequently in patients with PAI and the prevalence of pulmonary artery thrombosis has been increasing in the case of PAI. Furthermore, our report indicates that anticoagulation might be effective in preventing further vascular relapses.

Entities:  

Keywords:  Anticoagulation; Behçet’s syndrome; Prognosis; Pulmonary artery involvement; Relapse

Year:  2021        PMID: 33907905     DOI: 10.1007/s10067-021-05748-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  Pulmonary artery aneurysms in Behçet syndrome.

Authors:  Vedat Hamuryudan; Tarik Er; Emire Seyahi; Canan Akman; Hasan Tüzün; Izzet Fresko; Sebahattin Yurdakul; Füruzan Numan; Hasan Yazici
Journal:  Am J Med       Date:  2004-12-01       Impact factor: 4.965

2.  2018 update of the EULAR recommendations for the management of Behçet's syndrome.

Authors:  Gulen Hatemi; Robin Christensen; Dongsik Bang; Bahram Bodaghi; Aykut Ferhat Celik; Farida Fortune; Julien Gaudric; Ahmet Gul; Ina Kötter; Pietro Leccese; Alfred Mahr; Robert Moots; Yesim Ozguler; Jutta Richter; David Saadoun; Carlo Salvarani; Francesco Scuderi; Petros P Sfikakis; Aksel Siva; Miles Stanford; Ilknur Tugal-Tutkun; Richard West; Sebahattin Yurdakul; Ignazio Olivieri; Hasan Yazici
Journal:  Ann Rheum Dis       Date:  2018-04-06       Impact factor: 19.103

3.  Behçet syndrome: a contemporary view.

Authors:  Hasan Yazici; Emire Seyahi; Gulen Hatemi; Yusuf Yazici
Journal:  Nat Rev Rheumatol       Date:  2018-01-24       Impact factor: 20.543

4.  Pulmonary arterial aneurysms in Behçet's syndrome: a report of 24 cases.

Authors:  V Hamuryudan; S Yurdakul; F Moral; F Numan; H Tüzün; N Tüzüner; C Mat; Y Tüzün; Y Ozyazgan; H Yazïci
Journal:  Br J Rheumatol       Date:  1994-01

5.  Pulmonary manifestations in a group of patients with Behcet's disease.

Authors:  Amr Edrees; Sherif Naguib; Manal El Menyawi; Ihab Ismail; Hamdy Nagah
Journal:  Int J Rheum Dis       Date:  2015-09-09       Impact factor: 2.454

6.  Mortality in Behçet's disease.

Authors:  D Saadoun; B Wechsler; K Desseaux; D Le Thi Huong; Z Amoura; M Resche-Rigon; P Cacoub
Journal:  Arthritis Rheum       Date:  2010-09

Review 7.  Pulmonary vasculitis in behcet disease: a cumulative analysis.

Authors:  Oguz Uzun; Tekin Akpolat; Levent Erkan
Journal:  Chest       Date:  2005-06       Impact factor: 9.410

Review 8.  Behçet's syndrome: pulmonary vascular disease.

Authors:  Emire Seyahi; Hasan Yazici
Journal:  Curr Opin Rheumatol       Date:  2015-01       Impact factor: 5.006

9.  Surgical Treatment of Pulmonary Complications in Behçet's Syndrome.

Authors:  Hasan Tuzun; Emire Seyahi; Gul Guzelant; Buge Oz; Sebnem Batur; Ozkan Demirhan; Vedat Hamuryudan
Journal:  Semin Thorac Cardiovasc Surg       Date:  2018-07-19

Review 10.  Pulmonary manifestations in Behçet's syndrome.

Authors:  I Raz; E Okon; T Chajek-Shaul
Journal:  Chest       Date:  1989-03       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.